Showing posts with label medicare coverage allergy testing. Show all posts
Showing posts with label medicare coverage allergy testing. Show all posts

Saturday, 24 December 2016

Coding , Compliance and updates for the practicing Allergist

CPT Changes

Subsection Heading for Allergy and Clinical Immunology “…..which may include new or established patient office or other outpatient services (99201-99215), hospital observation services (99217-99220, 99224-99226), hospital care (99221-99233) consultations (99241—99255), emergency department services (99281-99285) nursing facility services (99304-99318), domiciliary, rest home or custodial care services (99324-99337), home services (99381-99429) should be reported using modifier 25.”

CPT Changes

  • Allergy testing Code Changes
  • (For administration of medications (eg, epinephrine, steroidal agents, antihistamines) for therapy for severe or intractable allergic reactions, use 96372)
  • 95004 – Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report by a physician, specify number of tests (deleted “by a physician”)
  • 95010 and 95015 – deleted
  • 95017 – Allergy testing, any combination of percutaneous (scratch, puncture, prick) and intracutaneous (intradermal) sequential and incremental, with venoms, immediate type reaction, including test interpretation and report. Specify number of tests
  • RVU value 2.52
  • 95018Allergy testing, any combination of percutaneous (scratch, puncture, prick) and intracutaneous (intradermal) sequential and incremental with drugs or biologicals, immediate type reaction, including test interpretation and report, specify number of test.
  • RVU value .86
  • 95024, 95027 – Deleted the wording “by a physician.”
  • New subsection – Ingestion Challenge Testing 


New Subsection – Ingestion Challenge Testing

  • Codes 95076 and 95079 are used to report ingestion challenge testing. Report 95076 for initial 120 minutes of testing time (ie, not physician face to face time). Report 95079 for each additional 60 minutes of testing time …
  • For total time less than 61 minutes (eg positive challenge resulting in cessation of testing). Report an evaluation and management service if appropriate.

Ingestion Challenge Testing

  • Patient assessment/monitoring activities for allergic reaction are not separately reported. Intervention therapy (eg injection of steroid or epinephrine) may be reported separately as appropriate.
  • For purposes of reporting testing times, if an E/M service is required, then testing time ends.

CPT Changes

  • 95076 – Ingestion challenge test (sequential and incremental ingestion of test items, eg, food, drug or other substance); initial 120 minutes – RVU value 3.42
  • +95079 – each additional 60 minutes of testing RVU value 2.41
  • Time will need to be documented in the testing document to support the coding
  • 95120 – 95134 – added “in the office or institution of the prescribing physician or other qualified health care professional” including allergenic extract:…
  • Pulmonary Coding Changes
  • Subsection instruction changes – same as allergy section for definition for E/M billing in addition to pulmonary billing
  • 94014, 94016 added ….physician or other qualified health care professional” to the code description.
  • Miscellaneous Code changes
  • 99000, 99001 – Handling and/or conveyance of specimen for transfer from the office to a laboratory…..delete “physician”

CPT Changes – Evaluation and Management Codes

Added the phrase “other qualified health care professional who may report evaluation and management services reported by a specific CPT Code”

Evaluation and Management Codes

“In the instance where a physician/qualified health care professional is on call for or covering for another physician / qualified health care professional, the patient encounter will be classified as it would have been by the physician qualified health care professional who is not available. When advanced practice nurses and physician assistants are working with physicians, they are considered as working in the exact same specialty and exact same subspecialties as the physician”

CPT Changes

  • Evaluation and management Code Changes
  • Added the phrase “other qualified health care professionals to all code descriptions
  • Category II CPT Code changes
  • 3750F Patient not receiving dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days

Evaluation & Management Codes

  1. Chronic Care coordination Services
  2. 99487- 99489

E/M Codes – 99487-99489 (Bundled by CMS Fee Schedule status)
  • 99487-99489 includes:
  • Communication (with patient, family members, guardian or caretaker, surrogate decision.makers, and/or other professionals regarding aspects of care.)
  • Communication with home health agencies other community services utilized by the patient.
  • Collection of health outcomes data and registry documentation.
  • Patient and/or family/caretaker education to support self management, independent living, and activities of daily living .
  • Assessment and support for treatment regimen adherence and medication management.
  • Identification of available community and health resources.
  • Facilitating access to care and services needed by the patient and/or family.
  • Development and maintenance of a comprehensive care plan.
E/M Codes 99495-99496 Transitional Care Management Services

Requires face to face encounter, initial patient contact and medication reconciliation within specific time frames. TCM requires an interactive contact with the patient or caregiver, as appropriate, within two business days of discharge. May be direct, telephonic, or by electronic means. Medication reconciliation and management must occur no later than the date of the face to face visit.
  • 99495 – Transitional Care Management Services.
  • Communication with the patient and/or caregiver within 2 business days of discharge.
  • Medication decision making of at least moderate complexity during the service period.
  • Face-to-face visit, within 14 calendar days of discharge.
  • 99496 – Transitional care management services.
  • Communication with patient – 2 business days.
  • Medical decision making of high complexity.
  • Face to face visit, within 7 calendar days of discharge.

Allergy Testing and Allergy Immunotherapy

Related Medicare Advantage Policy Guidelines:

 Antigens Prepared for Sublingual Administration (NCD 110.9)

 Challenge Ingestion Food Testing (NCD 110.12)

 Cytotoxic Food Tests (NCD 110.13)

 Food Allergy Testing and Treatment (NCD 110.11)

 Intravenous Histamine Therapy (NCD 30.6)

This information is being distributed to you for personal reference. The information belongs to UnitedHealthcare and unauthorized copying, use, and distribution are prohibited. This information is intended to serve only as a general reference resource and is not intended to address every aspect of a clinical situation. 

Physicians and patients should not rely on this information in making health care decisions. Physicians and patients must exercise their independent clinical discretion and judgment in determining care. Each benefit plan contains its own specific provisions for coverage, limitations, and exclusions as stated in the Member’s Evidence of Coverage (EOC)/Summary of Benefits (SB). 

If there is a discrepancy between this policy and the member’s EOC/SB, the member’s EOC/SB provision will govern. The information contained in this document is believed to be current as of the date noted.

The benefit information in this Coverage Summary is based on existing national coverage policy, however, Local Coverage
Determinations (LCDs) may exist and compliance with these policies is required where applicable. 

COVERAGE

Coverage Statement: Allergy testing and allergy immunotherapy (allergy therapy) are covered when Medicare coverage criteria are met.

Guidelines/Notes:

1. Allergy testing that may be covered include, but are not limited to:

a. Complete blood count (CBC) with differential (e.g., eosinophil count, IgE level, smear of a nasal secretions)

b. Chest X  -ray, when respiratory symptoms are present

c. Skin testing 

d. Total gamma globulins

e. Sputum exam 

f. Paranasal sinus X  -ray

g. Challenge ingestion - food testing

h. Radioallergosorbent Test (RAST) (CPT code 86003)

 Medicare does not have a National Coverage Determination (NCD) for RAST.

 Local Coverage Determinations (LCDs) which address IGE in Vitro Tests (e.g., RAST) exist and compliance with these LCDs is required where applicable. For state-specific LCDs, refer to the LCD Availability Grid (Attachment A).

 For states with no LCDs, refer to the MCG™ Care Guidelines, 20th edition, 2016, Quantitative Allergen-Specific IgE Antibody Assays ACG: A-0149 (AC) for coverage guidelines. 

(IMPORTANT NOTE: After searching the Medicare Coverage Database, if no state LCD or Local Article is found, then use the above referenced policy.)

 Committee approval date: September 20, 2016

2. Allergen immunotherapy to treat allergies is covered when:

a. Patient is examined by a physician

b. The physician who examines the patient, prepares the antigens and develops a plan of care and dosage regimen

Note: Physician should instruct member on self-administration if member is capable of doing the injections. If a member lives too far from the allergist (rural area) the allergist may prepare the antigens and send the reasonable supply to another physician or qualified healthcare professional for administration.

3. Reasonable Supply of Antigen Payment may be made for a reasonable supply of antigens that have been prepared for a particular patient if: 

(1) the antigens are prepared by a physician who is a doctor of medicine or osteopathy, and 

(2) the physician who prepared the antigens has examined the patient and has determined a plan of treatment and a dosage regimen.

Antigens must be administered in accordance with the plan of treatment and by a doctor of medicine or osteopathy or by a properly instructed person (who could be the patient) under the supervision of the doctor. 

The associations of allergists that CMS consulted advised that a reasonable supply of antigens is considered to be not more than a 12-month supply of antigens that has been prepared for a particular patient at any one time. 

The purpose of the reasonable supply limitation is to assure that the antigens retain their potency and effectiveness over the period in which they are to be administered to the patient. 

The following are examples of tests/services that are not covered but are not limited to:

a. Sublingual antigen; see the NCD for Antigens for Sublingual Administration (110.9) (Accessed December 17, 2015)

b. Intravenous histamine administration; see the NCD for Intravenous Histamines (30.6) (Accessed December 17, 2015)

c. Routine radioallergosorbent test (RAST) (see #1.h above)

d. Cytotoxicity testing/Bryan’s test; see the NCD for Cytotoxic Food Test (110.13) (Accessed December 17, 2015)

e. Urine autoinjection

f. Skin titration/Rinkel method

g. Provocative and neutralizing testing (subcutaneous) for food allergies; see the NCD for Food Allergy Testing and Treatment (110.11) (Accessed December 17, 2015)

h. Sublingual provocative test; see the NCD for Food Allergy Testing and Treatment (110.11) (Accessed December 17, 2015)
i. Serum allergy/histamine release tests 


TAGS:medicare coverage allergy testing, billing cpt 95165, cpt codes for allergy testing, how to bill for allergy injections, allergy billing coding, cpt code for allergy skin testing, how to bill for immunotherapy, cpt code 95004 reimbursement,